End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,437 KRW | -2.71% |
|
-7.05% | -43.98% |
May. 17 | Clinomics Inc. announced that it has received KRW 4 billion in funding | CI |
May. 14 | Clinomics Inc. announced that it expects to receive KRW 4 billion in funding | CI |
Business Summary
Number of employees: 71
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bio
62.0
%
| - | - | 7,077 | 62.0 % | - |
Food and Food Service
36.7
%
| - | - | 4,186 | 36.7 % | - |
Other
1.3
%
| - | - | 144 | 1.3 % | - |
Investment
0.0
%
| - | - | 1 | 0.0 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 23,083 | 100.0 % | 11,408 | 100.0 % | -50.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jong-Tae Jung
CEO | Chief Executive Officer | 62 | 21-03-23 |
Byung-Chul Kim
CEO | Chief Executive Officer | 59 | 11-06-20 |
Sung-Hun Lee
CTO | Chief Tech/Sci/R&D Officer | 47 | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Byung-Chul Kim
CEO | Chief Executive Officer | 59 | 11-06-20 |
Jong-Tae Jung
CEO | Chief Executive Officer | 62 | 21-03-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,886,113 | 33,440,117 ( 86.00 %) | 438,977 ( 1.129 %) | 86.00 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CLINOMICS INC. 1.14% | 435,029 | 1.14% | 460,469 $ |
Company contact information
![address Clinomics Inc.(A352770)](https://cdn.zonebourse.com/static/address/120976765.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-43.98% | 40.41M | |
+18.09% | 45.01B | |
+45.77% | 40.96B | |
-8.38% | 38.62B | |
+34.66% | 32.6B | |
-8.34% | 27.49B | |
+16.10% | 27.17B | |
+49.73% | 14.61B | |
+36.71% | 12.95B | |
-6.60% | 11.36B |
- Stock Market
- Equities
- A352770 Stock
- Company Clinomics Inc.